Terns Pharmaceuticals published a recent paper showing that Reinforcement Learning with Metacognitive Feedback (RLMF) improves an AI's ability to signal uncertainty by up to 63% compared to standard methods.

Public source

Publisher name

Public post

Metacognitive RL (Reinforcement Learning) offers a powerful way to tackle AI hallucinations by teaching models to recognize their own limits before they speak. ​A recent…

Log in to read the full post

Company

Terns Pharmaceuticals

Reimagining known biology to deliver high impact medicines

Industry
Biotechnology Research
Location
Foster City, US
Company size
51–200 employees

About Terns Pharmaceuticals

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.